Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $142,633 - $171,030
2,320 Added 45.43%
7,427 $542,000
Q4 2021

May 04, 2022

BUY
$53.63 - $62.52 $273,888 - $319,289
5,107 New
5,107 $318,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Offit Capital Advisors LLC Portfolio

Follow Offit Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Offit Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Offit Capital Advisors LLC with notifications on news.